Retatrutide targets all three receptors (GLP-1, GIP, and glucagon) simultaneously, and Phase 2 data showed up to 24.2% weight loss at 48 weeks
The use of the GLP-1 program should be done under the supervision and guidance of a medical professional
Key safety risks include hypoglycaemia when combined with insulin or sulphonylureas, gastrointestinal interactions, pancreatitis, gallbladder disease, and dehydration-related acute kidney injury
What GLP-1 medications does Henry Meds offer
First, a tumescent solution provides pain control by having a numbing solution, called lidocaine
Strength training is best because it helps preserve basal metabolic rate during weight loss